/
Antineoplastic agents By Dr Abdul Samad Salahuddin Antineoplastic agents By Dr Abdul Samad Salahuddin

Antineoplastic agents By Dr Abdul Samad Salahuddin - PowerPoint Presentation

edolie
edolie . @edolie
Follow
342 views
Uploaded On 2022-02-15

Antineoplastic agents By Dr Abdul Samad Salahuddin - PPT Presentation

Antineoplastic agents Antineoplastic agents are drugs used for the treatment of cancer malignancy tumor carcinoma sarcoma Leukemia or neoplasm Greek neo new Plasm formation Neoplasm refers to a group of diseases caused by several agents namely chemical compounds and radiant energy ID: 909048

agents cells antineoplastic dna cells agents dna antineoplastic alkylating drugs cancer mechanism bases normal tumors kill tumor groups agent

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Antineoplastic agents By Dr Abdul Samad ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Antineoplastic agents

By Dr Abdul Samad Salahuddin

Slide2

Antineoplastic agentsAntineoplastic agents are drugs used for the treatment of cancer, malignancy, tumor, carcinoma, sarcoma, Leukemia, or neoplasm (Greek neo = new, Plasm = formation). Neoplasm refers to a group of diseases caused by several agents, namely, chemical compounds and radiant energy. Cancer is characterized by an abnormal and uncontrolled, division of cells, which produces

tumours and invades adjacent normal tissues. Often, cancer cells separate themselves from the primary tumour, and are carried by the lymphatic system to reach distant sites of the organs, where they divide and form secondary tumors (metastasis).Not all tumors are cancerous, Benign Tumors do not Invade neighboring tissues and do not metastasize.

Slide3

Slide4

Slide5

Slide6

Slide7

Limitations of TherapyCancer cells very rapidly develop resistance to antineoplastic drugs.Differences between normal and neoplastic human cells are merely quantitative.Biochemical and morphological differences between normal and neoplastic cells are slight; therefore:

antineoplastic agents are devoid of selective toxicity to tumor cells.Antineoplastic agents kill cells by first-order kinetics, that is, they kill a constant fraction of cells.However, some of the cancer cells elude killing and one of these cells may restablize the tumour. It is extremely difficult to kill all the malignant cells.Most antineoplastic drugs are highly toxic to the patients.

Slide8

Classification:Antineoplastic agents are classified as follows:I. Alkylating agentsII. AntimetabolitesIII. AntibioticsIV. Plant products

V. EnzymesVI. HormonesVII. Immuno therapyVIII. Monoclonal antibodies

IX. Radio-therapeutic agentsX. Cyto-protective agentsXI. Miscellaneous.

Slide9

Slide10

Slide11

Slide12

Slide13

III. Plant Alkaloidsa. Vinca Alkaloids

Slide14

Slide15

Slide16

Trastuzumab

CisplatinCarboplatin

Slide17

Mechanism of Action of Alkylating agentsAlkylating agents involve reactions with guanine in DNA. These drugs add methyl or other alkyl groups onto molecules where they do not belong. This in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA.In the first mechanism an alkylating agent

attaches alkyl groups to DNA bases. This alteration results in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases.A second mechanism by which alkylating agents cause DNA damage is the formation of cross-bridges, bonds between atoms in the DNA. In this process, two bases are linked together by an alkylating agent that has two DNA binding sites. Cross-linking prevents DNA from being separated for synthesis or transcription.

Slide18

Example

N

Slide19

Slide20

Slide21

Slide22